cincorlogo.jpg
CinCor Pharma Appoints June Lee to Its Board of Directors
January 13, 2022 08:00 ET | CinCor Pharma Inc
BOSTON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced the appointment of the independent member June Lee, M.D. to the company’s Board of Directors. Dr. Lee...
cincorlogo.jpg
CinCor Pharma Announces Pricing of Initial Public Offering
January 06, 2022 23:26 ET | CinCor Pharma Inc
BOSTON, Jan. 06, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for...
cincorlogo.jpg
CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock
January 03, 2022 07:30 ET | CinCor Pharma Inc
BOSTON, Jan. 03, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of...